Table 3.
Hemodynamic parameters before and after increase dose of norepinephrine (n = 56).
| Before | After | P value | |
|---|---|---|---|
| HR (/min) | 105.9 ± 24.9 | 115.4 ± 27.2 | < 0.001 |
| SBP (mmHg) | 104 (98–113) | 123.5 (110.25–140) | < 0.001 |
| DBP (mmHg) | 55 (52–62) | 66.5 (61–70.75) | < 0.001 |
| MAP (mmHg) | 68.4 ± 8.5 | 86.5 ± 11.0 | < 0.001 |
| CVP (mmHg) | 14 (12–16.7) | 15 (13–18) | < 0.001 |
| SVRI (dyne-s-m2/cm5) | 1,530.3 ± 410.6 | 1,508.3 ± 453.2 | <0.001 |
| CIv (L/min/m2) | 3.2 ± 0.7 | 3.9 ± 0.8 | < 0.001 |
| CIp (L/min/m2) | 3.4 ± 0.9 | 3.9 ± 0.8 | 0.003 |
| SVV (%) | 13 (7–22.2) | 9.5 (6.2–19) | 0.04 |
| NE (ug/kg/min) | 0.20 ± 0.16 | 0.27 ± 0.17 | < 0.001 |
CIv, cardiac index obtained by FloTrac; CIp, cardiac index measured by pulse contour analysis of PiCCO; CVP, central venous pressure; DBP, diastolic blood pressure; HR, heart rate; MAP, mean arterial pressure; NE, norepinephrine; SBP, systolic blood pressure; SVRI, systemic vascular resistance index; SVV, stroke volume variation.